Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: results from the randomized phase 3 CELESTIAL trial

Basit Öğe Kaydı
dc.authoridCicin, Irfan/0000-0002-7584-3868
dc.authoridRimassa, Lorenza/0000-0001-9957-3615
dc.authoridDadduzio, Vincenzo/0000-0002-3193-6632
dc.authoridChan, Stephen Lam/0000-0001-8998-5480
dc.authorwosidCicin, Irfan/AAQ-5575-2020
dc.authorwosidRimassa, Lorenza/N-4884-2016
dc.authorwosidDadduzio, Vincenzo/AAA-6562-2019
dc.authorwosidChan, Stephen Lam/F-9149-2011
dc.contributor.authorWaidmann, O.
dc.contributor.authorAbou-Alfa, G. K.
dc.contributor.authorMeyer, T.
dc.contributor.authorCheng, A-L
dc.contributor.authorEl-Khoueiry, A. B.
dc.contributor.authorRimassa, L.
dc.contributor.authorRyoo, B-Y
dc.date.accessioned2024-06-12T11:24:08Z
dc.date.available2024-06-12T11:24:08Z
dc.date.issued2018
dc.departmentTrakya Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.endpage254en_US
dc.identifier.issn2296-5270
dc.identifier.issn2296-5262
dc.identifier.startpage254en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/26825
dc.identifier.volume41en_US
dc.identifier.wosWOS:000446816500618en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherKargeren_US
dc.relation.ispartofOncology Research And Treatmenten_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleCabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: results from the randomized phase 3 CELESTIAL trialen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu